세계의 노인 영양 시장 : 시장 예측 - 영양 유형별, 유형별, 유통 채널별, 용도별, 지역별 분석(-2032년)

According to Stratistics MRC, the Global Elderly Nutrition Market is accounted for $26.9 billion in 2025 and is expected to reach $42.3 billion by 2032 growing at a CAGR of 6.7% during the forecast period. Elderly nutrition is the thoughtful approach to nourishing older adults in a way that honors both their changing bodies and the wisdom of years. It focuses on providing balanced meals rich in protein, fiber, vitamins, and minerals while addressing age-related challenges such as reduced appetite, slower metabolism, and difficulty absorbing nutrients. This field emphasizes foods that support bone strength, immunity, cognitive health, and overall vitality. At its core, elderly nutrition blends tradition's respect for wholesome eating with modern insights, ensuring seniors maintain strength, dignity, and well-being as they move through life's later chapters.

Market Dynamics:

Driver:

Rapidly aging global population

The world's population is aging faster than ever, and this demographic shift is driving the Elderly Nutrition Market with unmistakable force. As life expectancy rises, more adults require targeted nutritional support to maintain strength, immunity, and cognitive clarity. Families and caregivers increasingly turn to specialized supplements and fortified foods to bridge dietary gaps caused by declining appetite or absorption issues. This growing senior population demands products that blend reliability with scientific precision, pushing manufacturers to innovate consistently to meet long-term wellness needs.

Restraint:

High product costs

High product costs weigh heavily on the Elderly Nutrition Market, making advanced nutritional solutions harder to access for many seniors. Premium ingredients, strict quality standards, and specialized formulations result in elevated pricing, limiting adoption in lower- and middle-income households. Even families who understand the importance of senior nutrition often struggle to justify recurring expenses. This cost burden dampens market growth and forces companies to rethink manufacturing efficiency.

Opportunity:

Healthcare integration

The growing integration of nutrition into mainstream healthcare offers a powerful opportunity for market expansion. Physicians, dietitians, and wellness programs increasingly recommend tailored nutritional products to manage chronic conditions, support muscle strength, and improve recovery. Hospitals and eldercare centers are adopting nutrition-based interventions as part of routine treatment plans, giving the market deeper credibility. This medical alignment strengthens trust and encourages innovation, as companies develop clinically backed formulas that complement traditional treatment. Thus, it drives the growth of the market.

Threat:

Regulatory hurdles

Regulatory hurdles stand as a persistent threat, slowing product approvals and complicating global expansion. Elderly nutrition products must meet stringent safety, labeling, and ingredient standards that vary across regions, creating delays and additional compliance costs. These complexities make innovation harder, particularly for smaller firms with limited resources. When regulations tighten or shift, companies must reformulate or update labels, disrupting supply chains and timelines. In a category centered on trust and safety, regulatory obstacles remain both necessary and challenging, shaping the market's pace of progress.

Covid-19 Impact:

Covid-19 cast a sharp spotlight on the importance of elderly nutrition. While supply chain disruptions caused temporary shortages and delivery delays, the pandemic also amplified demand for immunity-supportive foods, protein supplements, and vitamins tailored to aging bodies. Families became more cautious about senior health, shifting toward reliable, science-backed products. Telehealth consultations and online purchasing grew rapidly, reshaping buying habits. Covid-19 ultimately strengthened the market's long-term outlook by elevating awareness around nutritional resilience, high-quality support for older adults.

The antioxidants segment is expected to be the largest during the forecast period

The antioxidants segment is expected to account for the largest market share during the forecast period, due to rising focus on cellular protection and healthy aging. Antioxidants help combat oxidative stress, a key contributor to age-related decline, making them highly valued among seniors. Products enriched with vitamins C and E, selenium, and plant-based compounds are increasingly popular for supporting immunity and cognitive function. As chronic diseases become more common with age, the demand for antioxidant-rich supplements and foods grows steadily, securing this segment's position as the largest contributor.

The sarcopenia segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the sarcopenia segment is predicted to witness the highest growth rate, as more seniors seek targeted solutions to combat muscle loss. With aging reducing muscle mass and strength and fortified foods gain strong traction. Awareness campaigns by healthcare professionals highlight the importance of early intervention, further driving adoption. Innovations in digestible proteins and clinically supported formulas enhance trust and usability. As seniors strive to maintain mobility and independence, demand for products addressing sarcopenia accelerates sharply, giving this segment the highest projected CAGR.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising health awareness. Growing middle-class incomes, improved access to healthcare, and cultural importance placed on caring for older family members all contribute to strong demand. Governments across the region are also promoting healthy aging initiatives, encouraging the use of supplements and fortified foods. As urban lifestyles shift dietary habits, interest in convenient, reliable nutrition grows. These factors combine to secure Asia-Pacific as the market's primary anchor.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strong consumer awareness and early adoption of scientifically advanced nutrition solutions. Seniors and caregivers in this region actively seek clean-label and condition-specific formulations to support healthy aging. Robust retail networks, widespread online purchasing, and strong regulatory oversight enhance trust and accessibility. With innovation deeply embedded in the region's health and wellness culture, North America continues to push the boundaries of elderly nutrition, fueling its rapid growth trajectory.

Key players in the market

Some of the key players in Elderly Nutrition Market include Nestle Health Science, Ajinomoto Co., Inc., Abbott Laboratories, Mead Johnson Nutrition, Danone S.A., Otsuka Holdings Co., Ltd., Pfizer Inc., Novartis International AG, GlaxoSmithKline plc (GSK), Sanofi S.A., Bayer AG, BASF SE, Amway Corporation, Koninklijke DSM N.V., and Herbalife Nutrition Ltd.

Key Developments:

In October 2025, Nestle India has entered into a memorandum of understanding with the Ministry of Food Processing Industries to accelerate its investment in greenfield and brownfield food-sector projects across Odisha and existing manufacturing sites over the next 2-3 years, as part of its US $564 million expansion plan.

In June 2025, Nestle has inked research collaborations aimed at pioneering sustainable aquaculture practices, seeking to advance innovative, eco-efficient farming techniques and boost responsible seafood production in support of global food-security and environmental goals.

Nutrition Types Covered:

• Protein
• Antioxidants
• Minerals
• Iron
• Multi-vitamins
• Lipids
• Fibers

Types Covered:

• Enteral Elderly Nutrition
• Parenteral Elderly Nutrition

Distribution Channels Covered:

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Applications Covered:

• Obesity
• Physical Frailty
• Diabetes
• Cognitive Decline
• Renal Failures
• Sarcopenia
• Cancer
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Elderly Nutrition Market, By Nutrition Type

• 5.1 Introduction
• 5.2 Protein
• 5.3 Antioxidants
• 5.4 Minerals
• 5.5 Iron
• 5.6 Multi-vitamins
• 5.7 Lipids
• 5.8 Fibers

6 Global Elderly Nutrition Market, By Type

• 6.1 Introduction
• 6.2 Enteral Elderly Nutrition
• 6.3 Parenteral Elderly Nutrition

7 Global Elderly Nutrition Market, By Distribution Channel

• 7.1 Introduction
• 7.2 Hospital Pharmacies
• 7.3 Online Pharmacies
• 7.4 Retail Pharmacies

8 Global Elderly Nutrition Market, By Application

• 8.1 Introduction
• 8.2 Obesity
• 8.3 Physical Frailty
• 8.4 Diabetes
• 8.5 Cognitive Decline
• 8.6 Renal Failures
• 8.7 Sarcopenia
• 8.8 Cancer
• 8.9 Other Applications

9 Global Elderly Nutrition Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Nestle Health Science
• 11.2 Ajinomoto Co., Inc.
• 11.3 Abbott Laboratories
• 11.4 Mead Johnson Nutrition
• 11.5 Danone S.A.
• 11.6 Otsuka Holdings Co., Ltd.
• 11.7 Pfizer Inc.
• 11.8 Novartis International AG
• 11.9 GlaxoSmithKline plc (GSK)
• 11.10 Sanofi S.A.
• 11.11 Bayer AG
• 11.12 BASF SE
• 11.13 Amway Corporation
• 11.14 Koninklijke DSM N.V.
• 11.15 Herbalife Nutrition Ltd.